Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.
about
Lipid mediator-induced expression of bactericidal/ permeability-increasing protein (BPI) in human mucosal epitheliaThe carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexesEdema toxin impairs anthracidal phospholipase A2 expression by alveolar macrophages.A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein.The role of protegrins and other elastase-activated polypeptides in the bactericidal properties of porcine inflammatory fluids.Deacylation of purified lipopolysaccharides by cellular and extracellular components of a sterile rabbit peritoneal inflammatory exudate.Host defense functions of proteolytically processed and parent (unprocessed) cathelicidins of rabbit granulocytes.Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobialsReceptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Salmonella infection increases porcine antibacterial peptide concentrations in serum.Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.Shigella flexneri is trapped in polymorphonuclear leukocyte vacuoles and efficiently killedPorcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins.A Teleost Bactericidal Permeability-Increasing Protein Kills Gram-Negative Bacteria, Modulates Innate Immune Response, and Enhances Resistance against Bacterial and Viral Infection.An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease.Mobilization of potent plasma bactericidal activity during systemic bacterial challenge. Role of group IIA phospholipase A2.Lactoferrin: an alternative view of its role in human biological fluids.Basis for the failure of Francisella tularensis lipopolysaccharide to prime human polymorphonuclear leukocytes.Susceptibilities of oral bacteria and yeast to mammalian cathelicidinsInterleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis.Phospholipid synthesis by Staphylococcus aureus during (Sub)Lethal attack by mammalian 14-kilodalton group IIA phospholipase A2.The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.Of Men Not Mice: Bactericidal/Permeability-Increasing Protein Expressed in Human Macrophages Acts as a Phagocytic Receptor and Modulates Entry and Replication of Gram-Negative Bacteria.Cell-wall determinants of the bactericidal action of group IIA phospholipase A2 against Gram-positive bacteria.Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS.The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A2 attack.Autoantibodies against the bactericidal/permeability-increasing protein from inflammatory bowel disease patients can impair the antibiotic activity of bactericidal/permeability-increasing protein.
P2860
Q24534018-0484C225-3670-41B1-8BE3-532868AE9310Q28214380-52B9F4EB-9E75-470C-9F48-3947A6056829Q33309460-7CE3AF22-A6AD-41A8-BA7A-631B04D3A940Q33593645-D621E6AC-E4D7-423F-B886-E671B9577DA7Q33757436-26E1EB84-1C86-4817-AB66-F0A9DD1ACF37Q33876722-17268F87-1C87-459F-81A5-A3D9A8B6BA26Q34117610-4C21D237-E074-4E41-AAAC-F45B880A6A0DQ34775371-3B2EEBCA-D7D9-4C4C-9A83-1DCE1FFB8D95Q35176262-5A93E2FE-FB1E-4439-B4C3-4227BC8D02F4Q35232171-27196512-5970-4CBD-870C-4D3443DF3D3EQ35502327-23439999-7F9B-4E40-B153-CDE551E323A8Q35533491-2924138D-A08C-4D10-B58B-82A61239B5E1Q35544155-D21B4182-82EA-4470-ADCF-768080D06EF9Q35997086-5458FCCE-C7DF-4D59-9333-C515EC3997C3Q36603406-6BDE17EA-15D0-4555-A8FC-FC45FD2EA9DDQ36902238-3B6725A4-B31A-4378-8B4A-E3AB72B163B9Q37384421-B09526BD-785C-4AB0-9797-C1D15CCA233EQ38007176-B3C65758-48AE-4581-A437-0289E6652C84Q38313092-672850EB-5E24-411F-A13E-0BBE89B821C9Q39478909-59EF04F1-04C1-4225-BE1D-25A2294E2901Q39510203-807C1974-FF73-48D2-B09F-D4CF9B45E59FQ39514505-A614C017-758C-4600-ADBB-C88F2D0B9E63Q39759518-7941E2C1-965E-432E-AD24-C9709D07656DQ40460582-CADF79C2-7A69-4BCE-A99A-A91A4E100811Q40849785-68D7D03C-D313-4BA2-BD65-0CAC6E52C7DFQ43536172-9FBB19CA-22D2-4805-B6F6-03940B89BCB7Q49954392-301CF30B-8DCC-4E7A-9440-0D4646E27F6DQ54493774-456519F6-BDBE-4B81-B08E-C5A9E59D87BA
P2860
Extracellular accumulation of potently microbicidal bactericidal/permeability-increasing protein and p15s in an evolving sterile rabbit peritoneal inflammatory exudate.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@ast
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@en
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@nl
type
label
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@ast
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@en
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@nl
prefLabel
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@ast
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@en
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@nl
P2093
P2860
P356
P1476
Extracellular accumulation of ...... ritoneal inflammatory exudate.
@en
P2093
K Zarember
Y Weinrauch
P2860
P304
P356
10.1172/JCI117873
P407
P577
1995-04-01T00:00:00Z